Research map: Risperidone-Associated Diffuse Myalgia in a 5-Year-Old Child With Attention-Deficit/Hyperactivity Disorder: A Rare Tolerability-Limiting Adverse Effect

Back to the article

Papers in this map

  1. A method for estimating the probability of adverse drug reactions · C. A. Naranjo · 1981 · 11882 citations · Cited by this paper
  2. Successful Treatment of Acrodermatitis Continua of Hallopeau With Upadacitinib · 2026 · Related
  3. Canadian Guidelines on Pharmacotherapy for Disruptive and Aggressive Behaviour in Children and Adolescents with Attention-Deficit Hyperactivity Disorder, Oppositional Defiant Disorder, or Conduct Disorder · Daniel A. Gorman · 2015 · 92 citations · Cited by this paper
  4. Right Side Accessory Pathway Mediated Cardiomyopathy Treated with Amiodarone: First Adult Case Report · 2026 · Related
  5. Genetic Polymorphisms Associated With the Pharmacokinetics, Pharmacodynamics and Adverse Effects of Olanzapine, Aripiprazole and Risperidone · Paula Soria‐Chacartegui · 2021 · 63 citations · Cited by this paper
  6. Functional Recovery After Multimodal Noninvasive Neuromodulation for Multimorbid PTSD, Bipolar Mania With Psychosis, and Psoriatic Arthritis · 2026 · Related
  7. Rhabdomyolysis Reported for Children and Adolescents Treated with Antipsychotic Medicines: A Case Series Analysis · Kristina Star · 2012 · 43 citations · Cited by this paper
  8. Blood Pressure Targets in Thoracic Aortic Disease: A Practical Comparison of ACC/AHA Guidance and Post-2024 European Guidelines · 2026 · Related
  9. Adverse Events Associated with Risperidone Use in Pediatric Patients: A Retrospective Biobank Study · Kazeem Adeola Oshikoya · 2019 · 37 citations · Cited by this paper
  10. Effectiveness and Safety of Risankizumab in Crohn Disease After Failure of a First Line of Advanced Therapy: A Long-Term, Real-Life Study · 2026 · Related
  11. Risperidone Decreases Expression of Serotonin Receptor-2A (5-HT2A) and Serotonin Transporter (SERT) but Not Dopamine Receptors and Dopamine Transporter (DAT) in PBMCs from Patients with Schizophrenia · Samantha Álvarez-Herrera · 2024 · 15 citations · Cited by this paper
  12. Percutaneous Myocardial Revascularization in High- and Very High-Risk Non-ST Elevation Acute Coronary Syndromes: Real-World Insights From Two University Hospitals in Germany and Romania · 2026 · Related
  13. Physical Health Outcomes in Preschoolers with Prior Authorization for Antipsychotics · Yu‐Jung Jenny Wei · 2017 · 7 citations · Cited by this paper
  14. Outcomes With Peptide Receptor Radionuclide Therapy in Patients With Pheochromocytoma/Paraganglioma: A Center of Excellence Experience · 2026 · Related
  15. Evaluation of atypical antipsychotics associated rhabdomyolysis using the FDA adverse event reporting system database · Yin Yi · 2025 · 6 citations · Cited by this paper
  16. Abrocitinib as a Novel Therapeutic Option for Elastolytic Giant Cell Granuloma: A Case Report · 2026 · Related
  17. Salvage Therapy With Upadacitinib for Tofacitinib-Refractory Scarring Alopecia in an Asian Patient: Role of JAK1 Selective Inhibition · 2026 · Related
  18. Clozapine-Induced Pisa Syndrome During Lithium Treatment in a Patient With Bipolar Disorder and Methamphetamine Use Disorder · 2026 · Related

Source: OpenAlex (CC0)